142 related articles for article (PubMed ID: 11300660)
1. Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist.
Iwasaki T; Mihara S; Shimamura T; Kawakami M; Masui M; Hayasaki-Kajiwara Y; Naya N; Ninomiya M; Fujimoto M; Nakajima M
J Cardiovasc Pharmacol; 2001 Apr; 37(4):471-82. PubMed ID: 11300660
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.
Iwasaki T; Mihara S; Shimamura T; Kawakami M; Hayasaki-Kajiwara Y; Naya N; Fujimoto M; Nakajima M
J Cardiovasc Pharmacol; 1999 Jul; 34(1):139-47. PubMed ID: 10413080
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.
Douglas SA; Nambi P; Gellai M; Luengo JI; Xiang JN; Brooks DP; Ruffolo RR; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S273-6. PubMed ID: 9595458
[TBL] [Abstract][Full Text] [Related]
5. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
6. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
Hay DW; Luttmann MA; Beck G; Ohlstein EH
Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.
Iwasaki T; Hayasaki-Kajiwara Y; Shimamura T; Naya N; Nakajima M
Eur J Pharmacol; 2000 Jul; 400(2-3):255-62. PubMed ID: 10988342
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.
Wu-Wong JR; Dixon DB; Chiou WJ; Dayton BD; Novosad EI; Adler AL; Wessale JL; Calzadilla SV; Hernandez L; Marsh KC; Liu G; Szczepankiewicz B; von Geldern TW; Opgenorth TJ
Eur J Pharmacol; 1999 Feb; 366(2-3):189-201. PubMed ID: 10082200
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist.
Hoshino T; Yamauchi R; Kikkawa K; Yabana H; Murata S
J Pharmacol Exp Ther; 1998 Aug; 286(2):643-9. PubMed ID: 9694915
[TBL] [Abstract][Full Text] [Related]
10. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
[TBL] [Abstract][Full Text] [Related]
11. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.
Ohlstein EH; Nambi P; Douglas SA; Edwards RM; Gellai M; Lago A; Leber JD; Cousins RD; Gao A; Frazee JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8052-6. PubMed ID: 8058755
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255). 1. Study on structure-activity relationships and basic structure crucial for ET(A) antagonism.
Ishizuka N; Matsumura K; Sakai K; Fujimoto M; Mihara S; Yamamori T
J Med Chem; 2002 May; 45(10):2041-55. PubMed ID: 11985472
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature.
Moreland S; McMullen D; Abboa-Offei B; Seymour A
Br J Pharmacol; 1994 Jun; 112(2):704-8. PubMed ID: 8075891
[TBL] [Abstract][Full Text] [Related]
14. Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery.
Bax WA; Aghai Z; van Tricht CL; Wassenaar C; Saxena PR
Br J Pharmacol; 1994 Dec; 113(4):1471-9. PubMed ID: 7889304
[TBL] [Abstract][Full Text] [Related]
15. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
Clozel M; Breu V; Gray GA; Kalina B; Löffler BM; Burri K; Cassal JM; Hirth G; Müller M; Neidhart W
J Pharmacol Exp Ther; 1994 Jul; 270(1):228-35. PubMed ID: 8035319
[TBL] [Abstract][Full Text] [Related]
17. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
18. Effects of a potent, non-selective endothelin receptor antagonist, [Thr18, gamma-MeLeu19]-endothelin-1, on the isolated blood vessels.
Karaki H; Sudjarwo SA; Shimamoto N; Wakimasu M; Fujino M
Biochem Biophys Res Commun; 1995 Jul; 212(2):421-7. PubMed ID: 7626056
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
Henry PJ
Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Nishikibe M
Br J Pharmacol; 1994 Oct; 113(2):336-8. PubMed ID: 7834180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
